Dry media powder for the production of biotherapeutics and vaccines will be produced in a new facility in Scotland, in addition to an existing facility in New York.
Supplier News
Advertisement
A new GMP facility in Massachusetts will produce enzymes and other reagents for in-vitro diagnostics.
The supplier will add Allied Laboratories and AR Brown to its list of global partners.
A year after its merger with DSM Pharmaceutical Products, Patheon announces that it has filed an IPO.
A new demonstration facility in New York gives Sartorius’ customers hands-on access to bioprocessing systems and lab instruments.
EMD Millipore debuts a new cell-culture media compacting technology that will turn messy, dry powders into granules.
Waters announces it will introduce its new technology at the 63rd Society of Mass Spectrometry conference.
The Denmark facility will incorporate CMC’s Bioreactor 6Pack configuration in one manufacturing line.
UK-based Circassia invests approximately $377 million on Aerocrine and Prosonix, two companies focused on asthma.
SAFC’s new ADC wing in St. Louis, MO will feature commercial-scale manufacture of antibody-drug conjugates, and its Carlsbad, CA site will offer enhanced gene-therapy services.
Advertisement
Pall has agreed to be acquired by Danaher for $127.20 per share.
The new center will primarily support SAFC’s biopharmaceutical development and manufacturing clients in Asia.
Udit Batra, current head of Merck KGaA’s life science business, will lead the combined life science businesses following successful completion of Sigma-Aldrich acquisition.
The system is compatible with a wide range of industrial CHO cell lines.
Pall’s acquisition of BioSMB from Tarpon Biosystems expands its downstream continuous processing offerings.
Making the switch from batch to continuous manufacturing requires a thorough understanding of the process.
Genentech plans to invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR.
The new 2000-L bioreactor will double Rentschler’s single-use manufacturing capabilities.
Under a new agreement, Sigma-Aldrich will be the single supplier for Roche’s Biochemical Reagents product portfolio.
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.
The companies partnered to create more effective biopharmaceuticals through the exploitation of PASylation.
The new center represents AmerisourceBergen’s first facility erected specifically for clinical trial and commercial third-party logistics activities.
Thermo Fisher Scientific adds Advanced Scientific’s custom single-use systems and equipment to its bioprocessing offerings.
EMD Millipore will provide process development services for Precision Biologics’ preclinical monoclonal antibody.
Catalent will add potent containment for blending and granulation at its New Jersey manufacturing Center of Excellence.
The new facility will feature new research and development capabilities.
The new facility will feature dry powder cell-culture media capabilities.
Nelson Patterson has been elected to Pharma & Biopharma Outsourcing Association board.
Single-use components aid efficiency in automated personalized therapy manufacturing.
Biomanufacturing capacity expansion uses modular cleanroom design and single-use technologies.
Advertisement
Advertisement